Medtronic Spine and Biologics Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Medtronic Spine and Biologics's estimated annual revenue is currently $90.4M per year.(i)
  • Medtronic Spine and Biologics's estimated revenue per employee is $251,000

Employee Data

  • Medtronic Spine and Biologics has 360 Employees.(i)
  • Medtronic Spine and Biologics grew their employee count by -1% last year.

Medtronic Spine and Biologics's People

NameTitleEmail/Phone
1
Senior Case SpecialistReveal Email/Phone
2
Training & Education Specialist- MazorReveal Email/Phone
3
Sales ConsultantReveal Email/Phone
4
Sales Rep II, Interventional TherapiesReveal Email/Phone
5
Engineering ManagerReveal Email/Phone
6
Director Product DevelopmentReveal Email/Phone
7
Sr. Director Sales OperationsReveal Email/Phone
8
Principal R&D EngineerReveal Email/Phone
9
Senior Sales RepresentativeReveal Email/Phone
10
Sr. SupervisorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is Medtronic Spine and Biologics?

keywords:N/A

N/A

Total Funding

360

Number of Employees

$90.4M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Medtronic Spine and Biologics News

2022-04-20 - Medtronic names new chief scientific, medical, and regulatory ...

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator...

2022-04-06 - Could Medtronic's spine business be the next medtech spinoff?

"Given [Medtronic's] limited exposure to orthopedics outside of spine, we believe management might choose to spin off the spine business (...

2022-03-30 - Analysts see Medtronic's diabetes, spine businesses as most ...

Needham analysts published a report singling out the diabetes and spine businesses as possible spinoff options for Medtronic (NYSE:MDT).

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M3606%N/A
#2
$15M36020%N/A
#3
$35M3600%N/A
#4
$35M3608%N/A
#5
$35M3606%N/A